Therapy of Diabetes and Dyslipidemia in Acromegaly

Overview

Journal Pituitary

Specialty Endocrinology

Date 2003 Mar 18

PMID 12638723

Citations 2

Authors

G Tamburrano

C Durante

R Baldelli

Affiliations

Soon will be listed here.

Citing Articles

Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.

Berglund L, Brunzell J, Goldberg A, Goldberg I, Stalenhoef A Best Pract Res Clin Endocrinol Metab. 2014; 28(3):423-37.

PMID: 24840268 PMC: 4028601. DOI: 10.1016/j.beem.2013.10.002.

Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Berglund L, Brunzell J, Goldberg A, Goldberg I, Sacks F, Murad M J Clin Endocrinol Metab. 2012; 97(9):2969-89.

PMID: 22962670 PMC: 3431581. DOI: 10.1210/jc.2011-3213.

References

Baldelli R, Dieguez C, Casanueva F . The role of leptin in reproduction: experimental and clinical aspects. Ann Med. 2002; 34(1):5-18. DOI: 10.1080/078538902317338599. View

FINEBERG S, Merimee T . Acute metabolic effects of human growth hormone. Diabetes. 1974; 23(6):499-504. DOI: 10.2337/diab.23.6.499. View

Barrande G, Coste J, Ponvert D, Bertagna X, LUTON J, Bertherat J . Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab. 2000; 85(10):3779-85. DOI: 10.1210/jcem.85.10.6870. View

Malmstrom R, Taskinen M, Karonen S, Yki-Jarvinen H . Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia. 1996; 39(8):993-6. DOI: 10.1007/BF00403921. View

Flogstad A, Halse J, Bakke S, Lancranjan I, Marbach P, Bruns C . Sandostatin LAR in acromegalic patients: long-term treatment. J Clin Endocrinol Metab. 1997; 82(1):23-8. DOI: 10.1210/jcem.82.1.3572. View

Jap T, Ho L . Insulin secretion and sensitivity in acromegaly. Clin Physiol Biochem. 1990; 8(2):64-9. View

Kolaczynski J, Nyce M, Considine R, Boden G, Nolan J, Henry R . Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes. 1996; 45(5):699-701. DOI: 10.2337/diab.45.5.699. View

Koop B, Harris A, Ezzat S . Effect of octreotide on glucose tolerance in acromegaly. Eur J Endocrinol. 1994; 130(6):581-6. DOI: 10.1530/eje.0.1300581. View

Parkinson C, Drake W, Roberts M, Meeran K, Besser G, Trainer P . A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal. J Clin Endocrinol Metab. 2002; 87(4):1797-804. DOI: 10.1210/jcem.87.4.8432. View

10.

NIKKILA E, PELKONEN R . Serum lipids in acromegaly. Metabolism. 1975; 24(7):829-38. DOI: 10.1016/0026-0495(75)90129-8. View

11.

Roelfsema F, Frolich M . Glucose tolerance and plasma immunoreactive insulin levels in acromegalics before and after selective transsphenoidal surgery. Clin Endocrinol (Oxf). 1985; 22(4):531-7. DOI: 10.1111/j.1365-2265.1985.tb00153.x. View

12.

Gama R, Teale J, Wright J, Ferns G, Marks V . Hyperproinsulinaemia in acromegaly: evidence for abnormal pancreatic beta-cell function?. Ann Clin Biochem. 1997; 34 ( Pt 6):627-31. DOI: 10.1177/000456329703400605. View

13.

LAWRENCE J, TOBIAS C, LINFOOT J, BORN J, LYMAN J, Chong C . Successful treatment of acromegaly: metabolic and clinical studies in 145 patients. J Clin Endocrinol Metab. 1970; 31(2):180-98. DOI: 10.1210/jcem-31-2-180. View

14.

Hirose T, Kuroda T, Otsuki M, Takagi M, Yamamoto H, Motomura T . A patient with acromegaly who showed remarkable improvement of hyperglycemia after treatment with octreotide. Intern Med. 1997; 36(5):345-50. DOI: 10.2169/internalmedicine.36.345. View

15.

Wildbrett J, Hanefeld M, Fucker K, Pinzer T, Bergmann S, Siegert G . Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: relation to growth hormone levels and insulin-like growth factor I. Exp Clin Endocrinol Diabetes. 1997; 105(6):331-5. DOI: 10.1055/s-0029-1211774. View

16.

Hansen I, Tsalikian E, Beaufrere B, Gerich J, Haymond M, Rizza R . Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am J Physiol. 1986; 250(3 Pt 1):E269-73. DOI: 10.1152/ajpendo.1986.250.3.E269. View

17.

Hizuka N . Divergent effects of octreotide on glucose tolerance in patients with acromegaly. Intern Med. 1997; 36(5):319-20. DOI: 10.2169/internalmedicine.36.319. View

18.

Laron Z, Wang X, Klinger B, Silbergeld A, Wilcken D . Insulin-like growth factor-I decreases serum lipoprotein (a) during long-term treatment of patients with Laron syndrome. Metabolism. 1996; 45(10):1263-6. DOI: 10.1016/s0026-0495(96)90245-0. View

19.

Arosio M, Macchelli S, Rossi C, Casati G, Biella O, Faglia G . Effects of treatment with octreotide in acromegalic patients--a multicenter Italian study. Italian Multicenter Octreotide Study Group. Eur J Endocrinol. 1995; 133(4):430-9. DOI: 10.1530/eje.0.1330430. View

20.

Campbell J, Rastogi K . Growth hormone-induced diabetes and high levels of serum insulin in dogs. Diabetes. 1966; 15(1):30-43. DOI: 10.2337/diab.15.1.30. View